Milford, CTNCT06713616Now EnrollingIRB Ready

Treatment-Resistant Depression Clinical Trial in Milford, CT

Access cutting-edge treatment-resistant depression treatment through this clinical trial at a research site in Milford. Study-provided care at no cost to qualified participants.

Sponsored by Yale University

Quick Self-Assessment

See if you qualify for this Milford location

Preparing your pre-screening questions...

Expert Care in Milford

Access treatment-resistant depression specialists at no cost

IRB Approved

This study follows strict safety protocols and ethical guidelines

No-Cost Care

All study-related treatment-resistant depression treatment provided free

Apply for This Milford Location

Check if you qualify for this treatment-resistant depression clinical trial in Milford, CT

Secure & Confidential

Your information is protected and will only be shared with the research team.

Why Participate?

  • No-Cost Study Care

  • Local to Milford

    Convenient for CT residents

  • Cutting-Edge Treatment

    Access to innovative therapies

  • Expert Medical Care

    Close monitoring by specialists

  • Possible Compensation*

    For time and travel

*Compensation varies by study. Confirm details with coordinator.

Simple Process

  1. 1Submit this form
  2. 2Phone screening
  3. 3Visit Milford site if eligible
  4. 4Begin participation

About This Treatment-Resistant Depression Study in Milford

The purpose of this study is to compare the relative effectiveness, acceptability, and side effects of ketamine delivered through an IV (a drip into the arm) which is not currently FDA approved for use in the treatment of treatment-resistant depression (TRD) and Esketamine (Spravato®), taken as a nasal spray which has received FDA approval for use in the treatment of treatment-resistant depression (TRD) in the treatment of patients with treatment-resistant depression (TRD). The study will look a

Sponsor: Yale University

Who Can Participate

Inclusion Criteria

Provision of signed and dated informed consent form
Stated willingness to comply with all study procedures and availability for the duration of the study
Adults ages 18 or older
Diagnosis of major depressive disorder that is refractory to two or more antidepressant trials
Moderate or severe depression based on an initial MADRS score ≥ 25
Judged appropriate for ketamine or esketamine by clinician, independent of potential study participation
A female participant must be: a. Not of childbearing potential\*, OR b. Of childbearing potential and practicing a highly effective method of contraception (failure rate of \<1% per year when used consistently and correctly) and agrees to remain on a highly effective method while receiving study intervention and until 1 week after last dose - the end of relevant systemic exposure. The investigator will evaluate the potential for contraceptive method failure (e.g., noncompliance, recently initiated) in relationsh

Not sure if you qualify? Submit your interest and a study coordinator will help determine your eligibility.

Frequently Asked Questions

Q:Is this study available in Milford?

Yes, this clinical trial (NCT06713616) has an active research site in Milford, CT that is currently enrolling participants.

Q:Is it safe to participate?

Clinical trials follow strict safety guidelines and ethical standards. This study has been reviewed and approved, and participants are closely monitored by medical professionals. You can withdraw at any time.

Q:Will I be compensated?

Many clinical trials offer compensation for your time and travel expenses. Specific compensation details will be discussed during the screening process. All study-related medical care is provided at no cost.

Q:Can I leave the trial if I change my mind?

Absolutely. Participation is completely voluntary. You have the right to withdraw from the study at any time, for any reason, without penalty.

Still have questions? Our study coordinators are here to help.

Treatment-Resistant Depression Treatment Options in Milford, CT

If you're searching for treatment-resistant depression treatment options in Milford, CT, this clinical trial (NCT06713616) may be an excellent opportunity. Clinical trials provide access to cutting-edge treatments that aren't yet available to the general public, often at no cost to participants.

Our Milford research site is actively enrolling participants for this clinical trial. You'll receive care from experienced treatment-resistant depression specialists who are at the forefront of medical research. All study-related care, including examinations, treatments, and monitoring, is provided at no cost to qualified participants.

Looking for more options? Browse all treatment-resistant depression clinical trials near you to find additional studies recruiting in your area.

More Depression Trials in Milford, CT

See all depression clinical trials recruiting in Milford — not just this study.

Browse Depression Trials in Milford

Ready to Join in Milford?

Take the first step toward participating in this groundbreaking clinical trial

Secure · Expert Care · Milford, CT